Genmab A/S

PNK: GNMSF · Real-Time Price · USD
205.10
0.12 (0.06%)
At close: May 01, 2025, 2:19 PM

Genmab A/S Statistics

Share Statistics

Genmab A/S has 61.47M shares outstanding. The number of shares has increased by -2.46% in one year.

Shares Outstanding 61.47M
Shares Change (YoY) -2.46%
Shares Change (QoQ) 0.04%
Owned by Institutions (%) n/a
Shares Floating 59.41M
Failed to Deliver (FTD) Shares -
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 73.03K, so 0.12% of the outstanding shares have been sold short.

Short Interest 73.03K
Short % of Shares Out 0.12%
Short % of Float 0.12%
Short Ratio (days to cover) 4.35

Valuation Ratios

The PE ratio is 12.22 and the forward PE ratio is null. Genmab A/S's PEG ratio is 0.14.

PE Ratio 12.22
Forward PE n/a
PS Ratio 4.45
Forward PS n/a
PB Ratio 2.61
P/FCF Ratio 12.84
PEG Ratio 0.14
Financial Ratio History

Enterprise Valuation

Genmab A/S has an Enterprise Value (EV) of 87.05B.

EV / Sales 4.04
EV / EBITDA 8.98
EV / EBIT 11.2
EV / FCF 11.66

Financial Position

The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.03.

Current Ratio 5.25
Quick Ratio 5.24
Debt / Equity 0.03
Debt / EBITDA 0.11
Debt / FCF 0.14
Interest Coverage 55.86

Financial Efficiency

Return on Equity is 21.38% and Return on Invested Capital is 14.13%.

Return on Equity 21.38%
Return on Assets 17.12%
Return on Invested Capital 14.13%
Revenue Per Employee $8.03M
Profits Per Employee $2.92M
Employee Count 2,682
Asset Turnover 0.47
Inventory Turnover 15.89

Taxes

Income Tax 1.32B
Effective Tax Rate 14.4%

Stock Price Statistics

The stock price has increased by -25.81% in the last 52 weeks. The beta is 0.96, so Genmab A/S's price volatility has been higher than the market average.

Beta 0.96
52-Week Price Change -25.81%
50-Day Moving Average 203.92
200-Day Moving Average 225.61
Relative Strength Index (RSI) 57.79
Average Volume (20 Days) 1.96K

Income Statement

In the last 12 months, Genmab A/S had revenue of 21.53B and earned 7.84B in profits. Earnings per share was 122.21.

Revenue 21.53B
Gross Profit 20.54B
Operating Income 6.7B
Net Income 7.84B
EBITDA 9.7B
EBIT 9.28B
Earnings Per Share (EPS) 122.21
Full Income Statement

Balance Sheet

The company has 9.86B in cash and 1.03B in debt, giving a net cash position of 8.83B.

Cash & Cash Equivalents 9.86B
Total Debt 1.03B
Net Cash 8.83B
Retained Earnings 23.55B
Total Assets 45.81B
Working Capital 22.55B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.77B and capital expenditures -304M, giving a free cash flow of 7.47B.

Operating Cash Flow 7.77B
Capital Expenditures -304M
Free Cash Flow 7.47B
FCF Per Share 116.33
Full Cash Flow Statement

Margins

Gross margin is 95.42%, with operating and profit margins of 31.14% and 36.44%.

Gross Margin 95.42%
Operating Margin 31.14%
Pretax Margin 42.57%
Profit Margin 36.44%
EBITDA Margin 45.05%
EBIT Margin 31.14%
FCF Margin 34.69%

Dividends & Yields

GNMSF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield 8.18%
FCF Yield 7.79%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for GNMSF.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score 3.14
Piotroski F-Score 5